3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
12
Neurofibroma, Plexiform
6
Carcinoma, Non-Small-Cell Lung
4
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Muscle Invasive Bladder Cancer
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
AZD 6244
×
1 year
×
Clear all
No trials found.